Safety of therapy for allergic symptoms during pregnancy
- PMID: 28058
- DOI: 10.7326/0003-4819-89-2-234
Safety of therapy for allergic symptoms during pregnancy
Abstract
We undertook a literature review to document whether certain therapeutic measures could be considered safe during pregnancy in the allergic patient. With the possible exception of brompheniramine, the commonly used antihistamine drugs appear to be safe during pregnancy. The bronchodilators ephedrine and theophylline also appear to be safe, as does cromolyn. Corticosteroids do not appear to have adverse effects in pregnancy beyond those well recognized in nonpregnant patients. Because side effects are reduced when steroids are administered as aerosols in the nose or lung, these preparations seem well suited for use in pregnancy. The safety of allergic immunotherapy has been confirmed. For asthma, annual influenza vaccination is indicated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources